Yourgene

Yourgene Health is an international molecular diagnostics group which develops and commercialises genomic services and technologies. Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and infectious diseases.

All

Yourgene

products

YourgeneYourgene® Cystic Fibrosis Plus Italian test, CE IVD
Yourgene
Yourgene® Cystic Fibrosis Plus Italian test, CE IVD

Catalogue No.

CFITAB1

Technology

Fragment Analysis

No. of Reactions

25

Volume

Bolt on to CFEU2v1 to increase the mutation coverage for the Italian population.

Reproductive Health
Molecular

Not available for general supply in Australia. For Performance Evaluation Use only.

Support
YourgeneYourgene® Cystic Fibrosis Base Germany test, CE IVD
Yourgene
Yourgene® Cystic Fibrosis Base Germany test, CE IVD

Catalogue No.

CF1DEB2

Technology

Fragment Analysis

No. of Reactions

25

Volume

Detects the 31 mutations outlined by the G-BA for newborn screening in Germany.

Reproductive Health
Molecular

Not available for general supply in Australia. For Performance Evaluation Use only.

Support
YourgeneYourgene® Cystic Fibrosis Base France test, CE IVD
Yourgene
Yourgene® Cystic Fibrosis Base France test, CE IVD

Catalogue No.

CF030B1

Technology

Fragment Analysis

No. of Reactions

25

Volume

Detects the 29 most common mutations in the French population.

Reproductive Health
Molecular

Not available for general supply in Australia. For Performance Evaluation Use only.

Support
YourgeneYourgene® Cystic Fibrosis Lite test, CE IVD
Yourgene
Yourgene® Cystic Fibrosis Lite test, CE IVD

Catalogue No.

CF4HTB1

Technology

Fragment Analysis

No. of Reactions

25

Volume

Detects the 4 most common mutations in the European population.

Reproductive Health
Molecular

Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).

Support
YourgeneYourgene® Cystic Fibrosis Base test, CE IVD
Yourgene
Yourgene® Cystic Fibrosis Base test, CE IVD

Catalogue No.

CF2EUB2

Technology

Fragment Analysis

No. of Reactions

50

Volume

Detects the 50 most common mutations in the European population.

Reproductive Health
Molecular

Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).

Support